UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1398-1408

2020

Volltextzugriff (PDF)

Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?

Cancer, 2019-09, Vol.125 (18), p.3172-3183

2019

Volltextzugriff (PDF)

Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID‐19 pandemic among low‐income women in New York City

Cancer, 2021-07, Vol.127 (14), p.2399-2408

2021

Volltextzugriff (PDF)

Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center

Cancer, 2019-03, Vol.125 (5), p.690-697

2019

Volltextzugriff (PDF)

Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer

Gynecologic oncology reports, 2021-11, Vol.38, p.100843, Article 100843

2021

Volltextzugriff (PDF)

Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic

BMJ open, 2024-09, Vol.14 (9), p.e082658

2024

Volltextzugriff (PDF)

Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes

JCO oncology practice, 2022-03, Vol.18 (3), p.201-209

2022

Volltextzugriff (PDF)

Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum

Gynecologic oncology, 2017-08, Vol.146 (2), p.386-391

2017

Volltextzugriff (PDF)

Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study

European journal of obstetrics & gynecology and reproductive biology: X, 2019-04, Vol.2, p.100012-100012, Article 100012

2019

Volltextzugriff (PDF)

Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy

Gynecologic oncology, 2016-10, Vol.143 (1), p.18-21

2016

Volltextzugriff (PDF)

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis

PEC innovation, 2023-12, Vol.2, p.100138-100138, Article 100138

2023

Volltextzugriff (PDF)

Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

Journal of Gynecologic Oncology, 2017, 28(6), , pp.1-10

2017

Volltextzugriff (PDF)

Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population

Gynecologic oncology reports, 2023-08, Vol.48, p.101232-101232, Article 101232

2023

Volltextzugriff (PDF)

The influence of BRCA variants of unknown significance on cancer risk management decision-making

Journal of Gynecologic Oncology, 2019, 30(4), , pp.1-10

2019

Volltextzugriff (PDF)

Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer

American journal of obstetrics and gynecology, 2020-11, Vol.223 (5), p.725.e1-725.e9

2020

Volltextzugriff (PDF)

Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis

Gynecologic oncology reports, 2020-11, Vol.34, p.100641, Article 100641

2020

Volltextzugriff (PDF)

Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center

Journal of general internal medicine : JGIM, 2021-01, Vol.36 (1), p.35-42

2021

Volltextzugriff (PDF)

Enhanced recovery Pathways in gynecologic surgery: Are they safe and effective in the elderly?

Gynecologic oncology reports, 2021-11, Vol.38, p.100862-100862, Article 100862

2021

Volltextzugriff (PDF)

Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting

Gynecologic oncology reports, 2022-04, Vol.40, p.100941-100941, Article 100941

2022

Volltextzugriff (PDF)

Foreword: Genetics and Gynecologic Cancer: Opportunity and Nuance

Clinical obstetrics and gynecology, 2024-09

2024

Volltextzugriff (PDF)

Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors

Journal of Gynecologic Oncology, 2019, 30(2), , pp.1-9

2019

Volltextzugriff (PDF)

Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?

American journal of obstetrics and gynecology, 2012-11, Vol.207 (5), p.417.e1-417.e6

2012

Volltextzugriff (PDF)

Mental Health of US Medical Students During the COVID-19 Pandemic

Journal of general internal medicine : JGIM, 2021-10, Vol.36 (10), p.3295-3297

2021

Volltextzugriff (PDF)

Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies

Gynecologic oncology reports, 2020-11, Vol.34, p.100664, Article 100664

2020

Volltextzugriff (PDF)

Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban, Medicaid-predominant gynecology clinic: a step toward health equity

American journal of obstetrics and gynecology, 2024-06, Vol.230 (6), p.e108-e109

2024

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?

Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID‐19 pandemic among low‐income women in New York City

Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center

Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer

Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic

Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes

Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum

Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study

Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis

Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population

The influence of BRCA variants of unknown significance on cancer risk management decision-making

Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer

Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis

Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center

Enhanced recovery Pathways in gynecologic surgery: Are they safe and effective in the elderly?

Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting

Foreword: Genetics and Gynecologic Cancer: Opportunity and Nuance

Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors

Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?

Mental Health of US Medical Students During the COVID-19 Pandemic

Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies

Implementation of a smartphone survey and mainstreaming for genetic cancer risk assessment in a diverse, urban, Medicaid-predominant gynecology clinic: a step toward health equity

Suchergebnisse filtern